Designing Flexible Longitudinal Regimens: Supporting Clinician Planning for Discontinuation of Psychiatric Drugs

Title of the Paper

Designing Flexible Longitudinal Regimens: Supporting Clinician Planning for Discontinuation of Psychiatric Drugs

Paper Information

• Domain: Designing long-term clinical plans and technological support for psychiatric drug discontinuation
• Keywords: Clinical Decision Support Systems, Psychotropic Drugs, Antidepressants, Long-term Planning, Technology Design, Human-Computer Interaction

Research Background and Issues

• Problems or Challenges:

  • Discontinuing antidepressants can lead to severe withdrawal symptoms that may last for weeks or even months.
  • Clinical guidelines emphasize gradual tapering (stepwise dose reduction) over abrupt cessation to minimize withdrawal symptoms, but practices and strategies vary among providers.
  • There is a lack of standardized clinical research to guide the gradual discontinuation of antidepressants, leaving physicians to rely on intuition and experience to create tapering plans.
  • Discontinuation plans must consider factors such as the formulation of the prescribed drug, its half-life, and the patient's history (including psychological condition and prior withdrawal symptoms).
  • Plans may involve complex formulations (e.g., tablet splitting or liquid formulations) and require support from pharmacies and insurance companies.

• Significance:

  • The inherent complexity and individualization of the discontinuation process significantly impact patient health.
  • Socio-technical factors in healthcare (e.g., pharmacy and insurance company constraints) further complicate the creation and implementation of discontinuation plans.

• Research Motivation and Related Work:

  • Previous clinical decision support systems have often focused on one-time decisions (e.g., diagnostic predictions) and rarely support long-term, multi-step planning.
  • This study focuses on designing technological support to help healthcare practitioners overcome limitations and flexibly and effectively create antidepressant discontinuation plans.

Solution

• Proposed Method or Solution:

  • Designed and developed a clinical decision support tool called AT Planner to assist physicians in creating gradual antidepressant tapering plans.
  • The tool provides flexibility in clinical services by supporting various dosage adjustment models (linear tapering, exponential tapering), calculating and visualizing plans, and generating communication documents for pharmacies and patients.

• Innovations:

  • Proposed a set of design guidelines tailored to the needs of long-term planning, including flexible support for different tapering strategies, iterative plan adjustments, and seamless integration into clinical workflows.
  • Designed a tool to balance constraints such as physician experience variability and infrastructure limitations (e.g., insurance approvals and pharmacy capacity).

• Implementation Steps and Techniques:

  1. Needs Analysis: Conducted two rounds of interviews to gather physicians' tapering practices and technical requirements (8 physicians participated).
  2. Prototype Design: Developed low-fidelity prototypes based on design guidelines and validated functionality.
  3. High-Fidelity Prototype Implementation: Built a browser-based tool, AT Planner, using React and TypeScript.
  4. Feedback Testing: Engaged 8 physicians to test AT Planner in usage scenarios and collected iterative feedback.

Research Outcomes

• Specific Results:

  • Developed design guidelines for clinical decision support tools to aid in antidepressant discontinuation.
  • Implemented AT Planner, which supports multiple dosage forms (tablets, capsules, liquids), automatically generates tapering plans in linear or exponential modes, and allows flexible adjustments.
  • The tool generates patient instruction documents and pharmacy communication files to reduce repetitive data entry tasks.

• Advantages Over Existing Solutions:

  • Integrates diverse clinical needs, enabling physicians to flexibly adjust tapering plans.
  • Supports complex strategies (e.g., cross-drug tapering) and dynamic adjustments, accommodating physicians with varying levels of experience.
  • Reduces repetitive tasks and improves communication efficiency with pharmacies.

• Experimental or Evaluation Results:

  • Physicians reported that the tool significantly reduced the complexity of tapering plans and improved work efficiency, particularly for less experienced physicians.
  • Primary care physicians appreciated the tool's automation features, while psychiatrists valued its flexibility.

• Limitations and Future Directions:

  • The tool is not yet fully integrated into existing Electronic Medical Record (EMR) systems, which may increase the workload of dual documentation.
  • The heterogeneity of healthcare systems (e.g., varying pharmacy and insurance policies) limits the tool's applicability, requiring exploration of broader configuration options in the future.
  • Incorporating patient participation in the design process could better address collaborative needs between physicians and patients.

Conclusion

This study proposes an innovative approach to designing technological support tools for long-term tapering plans, offering new insights into the field of clinical decision support systems. It explores the impact of physician experience variability on design requirements and the challenges and opportunities of designing tools outside of EMR systems. This work provides valuable references for researchers and healthcare institutions developing similar technological tools.